Veracyte
VCYT
#3274
Rank
NZ$8.40 B
Marketcap
NZ$105.32
Share price
1.91%
Change (1 day)
134.74%
Change (1 year)

Market capitalization of Veracyte (VCYT)

Market cap: NZ$8.40 Billion

As of July 2026 Veracyte has a market cap of NZ$8.40 Billion. This makes Veracyte the world's 3274th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Veracyte from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$8.40 B44.9%
2025NZ$5.79 B5.19%
2024NZ$5.51 B73.52%
2023NZ$3.17 B18.47%
2022NZ$2.68 B-37.42%
2021NZ$4.28 B9.12%
2020NZ$3.92 B90.88%
2019NZ$2.05 B168.45%
2018NZ$0.76 B144.86%
2017NZ$0.31 B0.22%
2016NZ$0.31 B7.23%
2015NZ$0.29 B4.88%
2014NZ$0.27 B-25.57%
2013NZ$0.37 B

End of Day market cap according to different sources

On Jul 1st, 2026 the market cap of Veracyte was reported to be:

NZ$8.40 Billion
by Nasdaq info icon info icon
NZ$8.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Exact Sciences
EXAS
NZ$35.23 B 319.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ$0.99 B-88.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$2 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA